Back to News
Market Impact: 0.2
Twist Bioscience Consensus Price Target Increased by 29.51% to $153.59
Source: Nasdaq
Analyst EstimatesAnalyst InsightsHealthcare & Biotech
The average one-year analyst price target for Twist Bioscience was revised to $153.59 per share, up 29.51% from the prior estimate of $118.60 dated September 29, 2026. The figures are aggregate analyst targets; the article provides no additional context or reported market reaction.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.30
Ticker Sentiment
TWST0.45
More News
- Biotech stocks are surging. How investors can play the new drug innovation boom
- Goldman says these top tech stocks have plenty of upside ahead of earnings
- ProPetro’s 49% decline: how Fair Value spotted the warning signs
- Persistent Oil Prices Threaten Inflation Outlook
- IMDELLTRA® IN COMBINATION WITH IMFINZI® REDUCED RISK OF DEATH BY AN UNPRECEDENTED 58% IN FIRST-LINE EXTENSIVE STAGE SMALL CELL LUNG CANCER
- Could France’s debt crisis spread across Europe?